뒤로
InnoCare Pharma Limited(INCPF) 가격
INCPF 주가 차트
INCPF 수입
InnoCare Pharma Limited
$2.05
0%
$0
종가: Jan 23, 16:00:00 GMT-5
$2.05
0%
$0
애프터마켓: Jan 23, 18:47:30 GMT-5
최신 수익 결과: Q3 '25
보고됨: 2025-11-13
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
INCPF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
InnoCare Pharma Limited INCPF의 지난 분기 매출 실적은 어땠나요?
InnoCare Pharma Limited의 매출 추정치는 얼마인가요?
InnoCare Pharma Limited의 수익 품질 점수는 얼마인가요?
InnoCare Pharma Limited는 언제 수익을 보고하나요?
InnoCare Pharma Limited의 예상 수익은 얼마인가요?
InnoCare Pharma Limited은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$2.05
시가
$2.05
일일 범위
$2.05 - $2.05
52주 범위
$2.05 - $3.26
거래량
1.0K
평균 거래량
19
EPS(TTM)
-0.02
배당수익률
--
시가총액
$3.0B
INNOCARE PHARMA LTD란 무엇인가요?
InnoCare Pharma Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 1,146 full-time employees. The company went IPO on 2020-03-23. InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The firm focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The firm's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The firm is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The firm conducts its businesses in domestic and overseas markets.